J klastersky (45 risultati)

Hardcover. Condizione: Good. Sorry, No international shipping on this item.Ex-Library hardcover no dj (blue boards) with all the usual markings, attachments, and library wear. Text block clean and unmarked. Tight binding.

Hardcover. Condizione: Near Fine. Condizione sovraccoperta: Very Good. First edition. Near fine in very good dustwrapper with short tears and folds along the top edge.

Hardcover. Condizione: Wie neu. X, 280 S. ; Ill.; 27,5 cm, Like new. Shrink wrapped. Sprache: Englisch Gewicht in Gramm: 1120.

Paperback. Condizione: Brand New. 108 pages. 11.69x8.25x0.25 inches. In Stock.

Condizione: New.

Condizione: As New. Unread book in perfect condition.

Hardcover. Condizione: New. US SELLER SHIPS FAST FROM USA. SHRINK-WRAPPED NEW.

Condizione: As New. Unread book in perfect condition.

Condizione: New.

Hardcover. Condizione: Brand New. 238 pages. 9.50x6.50x0.75 inches. In Stock.

Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Hardcover: 19.3 x 0 x 27 cm. 1999. 290 p. Unread book. Like new! 9783540625483 Sprache: Englisch Gewicht in Gramm: 939.

Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condizione: Used. pp. x + 280 1st Edition.

Condizione: Used. pp. x + 280 56 Figures.

Condizione: Used. pp. x + 280.

Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Lung cancer is not a single disease process but is a group of biologically variable diseases. Therefore, accurate and complete diagnosis along with complete workup of the patient prior to decision-making in treatment is essential to devise the most appropriate treatment strategy. In North America adenocarcinoma of the lung now accounts for about 40% of all lung cancers and stage for stage these tumors have a poorer prognosis than squamous cell cancers of the lung. Many prognostic indicators have been identified such as genetic markers and neuroen docrine differentiation, which have important roles to play in identifying the patients who would benefit most from active treatment. Screening and early detection have been thought to be sine qua non in early diagnosis of lung cancer. However, a number of controlled trials assessing the value of annual screening for lung cancer have demonstrated in some studies that chest X-rays and/or cytology screening may improve stage distribution, resectability, survival, and fatality but has not shown an impact on disease-specific mortality rates. The Mayo Clinic lung project compar ing quarterly chest X-rays and sputum cytology with routine care in more than 10 000 male smokers indicated that 5-year survival following treatment in the screened patients was better than rates in contemporary clinical practice. However, arguments have been ad vanced as to factors that might have biased the clinical benefits. Other trials are currently under way to deal with this issue along with new molecular markers that may enhance sputum sensitivity.…

Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Lung cancer is not a single disease process but is a group of biologically variable diseases. Therefore, accurate and complete diagnosis along with complete workup of the patient prior to decision-making in treatment is essential to devise the most appropriate treatment strategy. In North America adenocarcinoma of the lung now accounts for about 40% of all lung cancers and stage for stage these tumors have a poorer prognosis than squamous cell cancers of the lung. Many prognostic indicators have been identified such as genetic markers and neuroen docrine differentiation, which have important roles to play in identifying the patients who would benefit most from active treatment. Screening and early detection have been thought to be sine qua non in early diagnosis of lung cancer. However, a number of controlled trials assessing the value of annual screening for lung cancer have demonstrated in some studies that chest X-rays and/or cytology screening may improve stage distribution, resectability, survival, and fatality but has not shown an impact on disease-specific mortality rates. The Mayo Clinic lung project compar ing quarterly chest X-rays and sputum cytology with routine care in more than 10 000 male smokers indicated that 5-year survival following treatment in the screened patients was better than rates in contemporary clinical practice. However, arguments have been ad vanced as to factors that might have biased the clinical benefits. Other trials are currently under way to deal with this issue along with new molecular markers that may enhance sputum sensitivity.…

Taschenbuch. Condizione: Neu. Progress and Perspective in the Treatment of Lung Cancer | Paul Van Houtte (u. a.) | Taschenbuch | Medical Radiology | x | Englisch | 2011 | Springer | EAN 9783642641404 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Condizione: New. pp. x + 280 Softcover Reprint of the Original 1st Edition 1999.

Condizione: gut. 1999. Progress and Perspective in the Treatment of Lung Cancer (Medical Radiology) In deutscher Sprache. pages.

Paperback. Condizione: Brand New. reprint edition. 290 pages. 10.63x0.70x7.60 inches. In Stock.

Hardcover. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Paperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condizione: New. In English.

Condizione: New. In English.

Gebunden. Condizione: New. Despite the major developments in the therapeutic armamentarium for the treatment of infection, the morbidity and mortality of this complication remains very high in patients with compromised defences. Cancer and its treatment represents a major predispo.

Condizione: New. Despite the major developments in the therapeutic armamentarium for the treatment of infection, the morbidity and mortality of this complication remains very high in patients with compromised defences. This title presents a comprehensive review of some of the most crucial and challenging aspects of the infectious complications in cancer patients. Editor(s): Klastersky, Jean. Series: Cancer Treatment and Research. Num Pages: 290 pages, black & white illustrations. BIC Classification: MJCL. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 234 x 156 x 17. Weight in Grams: 1330. . 1996. 1995th Edition. hardcover. . . . .…

Buch. Condizione: Neu. Neuware - Despite the major developments in the therapeutic armamentarium for the treatment of infection, the morbidity and mortality of this complication remains very high in patients with compromised defences. Cancer and its treatment represents a major predisposing condition to a variety of infections. These adverse events are still with us, in spite of much progress in the therapy of infectious disease, since cancer therapy is becoming more aggressive, yet further lowering the host's capacity to cope with infections. Moreover, the pathogens adapt effectively to drugs, and at a pace that might outrun industry's capability to produce new agents. Finally, new pathogens are appearing as a consequence of both selection and severe immunosuppression. Infection is so common among cancer patients that its diagnosis and management represent a daily challenge to all oncologists, who must continually strive to keep abreast of developments in the area. The present comprehensive review of the most crucial and challenging aspects of the infectious complications in cancer patients will help them to do just that.…